AAPL   394.51 (+2.82%)
MSFT   214.37 (+0.33%)
FB   246.97 (+0.78%)
GOOGL   1,559.78 (+1.35%)
AMZN   3,285.07 (+2.66%)
BABA   258.10 (-1.11%)
MU   50.90 (+0.39%)
GE   6.78 (+1.35%)
TSLA   1,673.09 (+8.32%)
AMD   56.52 (+1.13%)
T   29.87 (-0.86%)
ACB   12.54 (+4.33%)
F   6.20 (+1.64%)
GILD   77.81 (+1.95%)
NFLX   562.11 (+2.44%)
BA   182.68 (+2.38%)
AAPL   394.51 (+2.82%)
MSFT   214.37 (+0.33%)
FB   246.97 (+0.78%)
GOOGL   1,559.78 (+1.35%)
AMZN   3,285.07 (+2.66%)
BABA   258.10 (-1.11%)
MU   50.90 (+0.39%)
GE   6.78 (+1.35%)
TSLA   1,673.09 (+8.32%)
AMD   56.52 (+1.13%)
T   29.87 (-0.86%)
ACB   12.54 (+4.33%)
F   6.20 (+1.64%)
GILD   77.81 (+1.95%)
NFLX   562.11 (+2.44%)
BA   182.68 (+2.38%)
AAPL   394.51 (+2.82%)
MSFT   214.37 (+0.33%)
FB   246.97 (+0.78%)
GOOGL   1,559.78 (+1.35%)
AMZN   3,285.07 (+2.66%)
BABA   258.10 (-1.11%)
MU   50.90 (+0.39%)
GE   6.78 (+1.35%)
TSLA   1,673.09 (+8.32%)
AMD   56.52 (+1.13%)
T   29.87 (-0.86%)
ACB   12.54 (+4.33%)
F   6.20 (+1.64%)
GILD   77.81 (+1.95%)
NFLX   562.11 (+2.44%)
BA   182.68 (+2.38%)
AAPL   394.51 (+2.82%)
MSFT   214.37 (+0.33%)
FB   246.97 (+0.78%)
GOOGL   1,559.78 (+1.35%)
AMZN   3,285.07 (+2.66%)
BABA   258.10 (-1.11%)
MU   50.90 (+0.39%)
GE   6.78 (+1.35%)
TSLA   1,673.09 (+8.32%)
AMD   56.52 (+1.13%)
T   29.87 (-0.86%)
ACB   12.54 (+4.33%)
F   6.20 (+1.64%)
GILD   77.81 (+1.95%)
NFLX   562.11 (+2.44%)
BA   182.68 (+2.38%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AmgenGilead SciencesBiogenSeattle GeneticsNOVOZYMES A/S/S
SymbolNASDAQ:AMGNNASDAQ:GILDNASDAQ:BIIBNASDAQ:SGENOTCMKTS:NVZMY
Price Information
Current Price$253.98$77.81$282.02$176.25$58.48
52 Week RangeBuyHoldHoldBuyHold
Beat the Market™ Rank
Overall Score2.22.01.71.30.7
Analysis Score2.32.12.12.30.0
Community Score3.03.33.02.51.8
Dividend Score3.32.50.00.00.8
Ownership Score1.01.01.01.00.0
Earnings & Valuation Score1.31.32.50.60.6
Analyst Ratings
Consensus RecommendationBuyHoldHoldBuyHold
Consensus Price Target$246.08$79.65$307.75$148.28N/A
% Upside from Price Target-3.11% downside2.37% upside9.12% upside-15.87% downsideN/A
Trade Information
Market Cap$146.50 billion$97.60 billion$45.51 billion$29.98 billion$17.37 billion
Beta0.940.70.541.460.74
Average Volume2,654,8387,775,7812,093,0691,066,55426,360
Sales & Book Value
Annual Revenue$23.36 billion$22.45 billion$14.38 billion$916.71 million$2.15 billion
Price / Sales6.404.353.2033.288.06
Cashflow$19.28 per share$7.44 per share$39.06 per shareN/A$1.59 per share
Price / Cash13.1710.467.22N/A36.72
Book Value$16.28 per share$17.90 per share$73.93 per share$10.95 per share$5.79 per share
Price / Book15.604.353.8116.1010.10
Profitability
Net Income$7.84 billion$5.39 billion$5.89 billion$-158,650,000.00$472.79 million
EPS$14.82$6.14$33.57($1.33)N/A
Trailing P/E Ratio19.9020.008.70N/A0.00
Forward P/E Ratio15.1311.608.94N/A33.61
P/E Growth$2.13$3.32$0.60N/A$25.92
Net Margins32.03%21.84%40.76%-32.81%22.31%
Return on Equity (ROE)90.75%35.44%49.22%-16.51%29.34%
Return on Assets (ROA)15.44%12.84%24.26%-13.88%16.10%
Dividend
Annual Payout$6.40$2.72N/AN/A$0.52
Dividend Yield2.52%3.50%N/AN/A0.89%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio43.18%44.30%N/AN/AN/A
Years of Consecutive Dividend Growth9 Years4 YearsN/AN/AN/A
Debt
Debt-to-Equity Ratio3.16%1.00%0.39%N/A0.37%
Current Ratio1.59%3.04%1.73%4.51%1.53%
Quick Ratio1.28%2.92%1.54%4.18%0.98%
Ownership Information
Institutional Ownership Percentage75.73%78.74%87.34%94.61%0.13%
Insider Ownership Percentage0.36%0.13%0.54%31.10%N/A
Miscellaneous
Employees23,40011,8007,4001,6056,427
Shares Outstanding588.25 million1.25 billion163.19 million173.10 million297.00 million
Next Earnings Date7/28/2020 (Confirmed)8/4/2020 (Estimated)7/22/2020 (Confirmed)7/30/2020 (Confirmed)8/13/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.